Von Hippel-Lindau (VHL) disease is a hereditary cancer syndrome with poor survival. The 35 current recommendations have proposed uniform surveillance strategies for all patients, neglecting 36 the obvious phenotypic varieties. In this study, we aim to confirm the phenotypic heterogeneity in 37 VHL disease and the underlying mechanism. A total of 151 parent-child pairs were enrolled for 38 genetic anticipation analysis, and 77 sibling pairs for birth order effect analysis. Four statistical 39 methods were used to compare the onset age of patients among different generations and different 40 birth orders. The results showed that the average onset age was 18.9 years earlier in children than 41 in their parents, which was statistically significant in all of the four statistical methods. 42
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Biosystems), containing 5 μL 2X SYBR master mix (Takara), 30ng genomic DNA, 300nmol/L 139 telomere primer Tel1 and 900 nmol/L Tel2, or 200 nmol/L single copy gene primer 36B4u and 500 140 nmol/L 36B4d. The primer sequences and PCR reaction procedure were described in our previous 141 study (WANG et al. 2017 ). Whenever possible, samples from different groups were run on the 142 same plate. A standard curve was constructed to assess the amplification efficiency (E) using a 143 control DNA sample (male, 45 years old) diluted by 1/4 serial from 50ng to 0.19ng, and the same 144 sample was detected in every batch of PCRs as the inter-run calibration. The telomere repeats (T) 145 was described by (E Tel,sample ) -Ct(Tel,sample) /(E Tel,calibrator ) -Ct(Tel,calibrator) , and the copy number of 36B4 (S) 146
was (E 36B4,sample ) -Ct(36B4,sample) /(E 36B4,calibrator ) -Ct(36B4,calibrator) . Relative telomere length (RTL) was 147 calculated by T/S. Age-adjusted RTL (aRTL) was obtained based on the telomere-age curve 148 constructed in our study before (NING et al. 2014) . 149
Statistical Analysis 150
Patients' entire lifetimes from birth until death or the end of follow-up in Dec 2016 were 151 included for analysis, and the median observation time was 39.3 years/person (range 1-75 years) 152 with a total 10860 person-years. The survival of patients and age-related penetrance of the five 153 VHL-associated tumors were analyzed using Kaplan-Meier plots and log-rank test. For the 154 analysis of genetic anticipation and birth order effect, we first used paired t-test to examine the 155 difference of onset age between affected patient pairs. Considering the truncating bias caused by 156 clinical data in paired t-test, we confirmed the results using the nonparametric method of 9 / 22 generation on phenotype when we included both affected and unaffected patients (BOONSTRA et al. 161 2010) . 162
Statistical analyses were performed using SPSS13.0 and R software, and a two-sided p-value 163 of less than 0.05 was considered to be statistically significant. 164
Data Availability 165
The authors affirm that all data necessary for confirming the conclusions of the article are 166 present within the article, figures, tables and supplementary files. 167
Results

168
Genetic anticipation in different generations 169
Genetic anticipation was analyzed in 151 parent-child pairs from 80 VHL families. As we 170 reported before, the age-related penetrance in children was obviously higher than that in their 171 parents (p<0.001) (Figure1), and the result was not affected by mutation origin and mutation type 172 ( Figure S1 ). In this study, we further analyzed the five common VHL-related tumors CHB, RA, 173 RCC, PCT and PHEO, respectively. The results showed that children had higher age-related 174 penetrance in all five tumors than their parents (Figure1). To further support our results, we 175 assessed the anticipation in 20 grandparents-parents-children groups from 16 families. The data 176 revealed that patients showed higher age-related penetrance in successive generations (p<0.001) 177
( Figure 1) . 178
To evaluate the exact difference of onset age between parents and children, we analyzed the 179 114 tumor-affected parent-child pairs and found that the average onset age was 18.9 years earlier 180 in children (Table 1 ) (p<0.001), which was 2.1 years longer than we previously reported in 34 181 parent-child pairs (NING et al. 2014) . Considering the possible bias caused by truncating data, the 10 / 22 result was reanalyzed using RY1 and RY2 with the affected parents-children pairs and at last by 183 CPH model with affected and non-affected VHL patients. As expected, the difference of onset age 184 between parents and children was statistically significant in all the three methods (Table 1 and 185 Table S2 ). For the onset age of the five common VHL-related tumors respectively, a similar 186 tendency was observed (Table S3 ). The mean of onset age difference (MOAD) ranged from 17.2 187 years (CHB) to 34.6 years (PHEO) in different tumors. 188
Birth order effect in the same generation 189
Given that the next generation showed a much earlier onset age than the first generation, we 190 further assessed the phenotypic heterogeneity in the same generation, which was called the birth 191 order effect. A total of 77 sibling pairs from the identical parents were analyzed, and the 192 distribution of onset age similarly displayed a "shift to left" phenomenon in younger siblings 193 (p=0.036) ( Figure 2 ). On average, the first-born siblings were affected by VHL-associated tumors 194 5.6 years later than the other ones, which was statistically significant in paired t-test (p<0.001), 195 RY1 (p<0.05) and RY2 (p<0.05) (Table 2) . Interestingly, when we analyzed the data only in the 196 paternal sibling pairs, the birth order effect disappeared ( Figure 2 and Table 2 ). In contrast, in the 197 maternal sibling pairs, the MOAD increased to 8.3 years later between the first-born siblings and 198 others ( Figure 2 and Table 2) . 199
Telomere length and intra-family phenotypic diversity in VHL disease 200
The relationship between telomere length and intra-family phenotypic diversity for VHL 201 disease was next investigated. A total of 55 parent-child pairs with data of telomere length were 202 enrolled for analysis, and the result showed that in 80% (44/55) pairs, children had significantly 203 shorter aRTL than their parents (p<0.001) ( Figure 3 ). Furthermore, in the 33 parent-child pairs 204 with clear onset ages, 28 children had younger onset age with shorter aRTL, while their parents 205 had older onset age with longer aRTL (Table 3) . Among the 16 families with three generations, 206 only 3 families were available for DNA samples of three generations (Family 42, 48, 66), and all 207 of them displayed a tendency of shorter telomere length along with generations ( Figure S2 ). With 208 regard to the sibling pairs, 16 out of 25 pairs showed relatively shorter aRTL in the younger 209 siblings, but the result was not statistically significant (p=0.585) ( Figure 3 ). In the 19 210 tumor-affected sibling pairs, only 8 younger patients had shorter aRTL with younger onset age 211 (Table S4 ). The results indicated that telomere shortening was associated with genetic anticipation 212 in VHL families, while the association between telomere length and birth order effect might be 213 uncertain. 214
Survival of VHL patients in different generations and birth order 215
In the 151 parent-child pairs, 58 parents and 10 children died. The median survival for 216 parents was 62 years old, while the survival for children was undefined ( Figure 4 ). No significant 217 difference was observed for overall survival between parents and children (p=0.834) ( Figure 4 ). 218
Similarly, there was no difference between the overall survival for the first-born patients and the 219 other siblings (p=0.390) ( Figure 4 ). Considering the diagnostic and therapeutic improvement in 220 the next generation and later-born siblings, the similar overall survival in some sense confirmed 221
t-test is the most common method used for anticipation analysis, but it may introduce a truncation 249 bias, which will increase the type I error (HEIMAN et al. 1996) . To lower the truncation bias 250 caused by paired t-test, we further used two special statistical methods for genetic anticipation 251 analysis (RY1 and RY2) in this study, reaching the same results. However, all the three methods 252 are carried out with affected parent-child pairs, missing the data of unaffected patients. Thus, the 253 CPH model was finally used to confirm GA with all the 151 parent-child pairs. As expected, the 254 difference of onset age between parents and children is significant in all the four statistical 255 methods. 256 GA and birth order effect have also been thought to be the myth caused by the improvement 257 of diagnosis and surveillance in the younger patients, which is a source of ascertainment bias. 258
People tend to take more active surveillance plan when they have relatives diagnosed with the 259 hereditary disease, and this may lead to early detection of tumors before symptom. To reduce this 260 kind of bias, we only analyzed the data of patient pairs presenting symptoms. It turned out that the 261 differences of onset age between different generations and different birth orders were highly 262 significant ( before their parents present symptoms in 24% parent-child pairs, and similarly, about 38% siblings 264 born in later order suffer tumors before the first-born patients become symptomatic. Thus, the 265 ascertainment bias will not influence the final conclusion in our study. 266
To explore the molecular mechanism for genetic anticipation, we measured the age-adjusted 267 relative telomere length of blood leukocytes in 10 parent-child pairs in our previous study and 268
found that the age-adjusted telomere length was significantly shorter in a child than in his or her 269 parent in all of the 10 parent-child pairs (NING et al. 2014 ). Furthermore, VHL patients showed 270 significantly shorter telomere length than healthy family controls, and a positive correlation was 271 found between telomere length and onset age of the five major VHL related tumors, respectively 272 (WANG et al. 2017). However, in another study from Canada on genetic anticipation with 15 VHL 273 patients, only granulocyte telomeres from VHL patients were significantly shorter than those from 274 healthy controls, and no significant difference was observed between different generations in the 6 275 parent-child pairs, implying that genetic anticipation in VHL is not caused by telomere 276 abnormalities (ARONOFF et al. 2018). The different results in the two studies above may be due to 277 bias caused by the small sample size and different methods in measuring the telomere length. In 278 this study, we evaluate the relationship between telomere shortening and genetic anticipation in a 279 large VHL cohort and confirm that the age-adjusted relative telomere length was shorter in 280 children than in their parents in 44 out of 55 parent-child pairs. As we all know, the telomeres in 281 most cells shorten throughout human life, meaning that the telomere length would be influenced 282 by age in which the blood sample was collected. Therefore, we use the age-adjusted relative 283 telomere length (calculated as the difference between predicted normal relative telomere length at 284 the DNA-obtained age and the relative telomere length actually measured) instead of relative 285 telomere length in our analysis. The results confirm that telomere shortening is the molecular 286 mechanism for genetic anticipation in VHL families. 287
Nevertheless, telomere shortening seems not to play a role in the mechanism of birth order 288 effect in VHL disease. Although parous women have been reported to have shorter telomere length 289 than nulliparous women (POLLACK et al. 2018), we did not observe significant difference for 290 telomere length between siblings in the first order and others. Currently, there exist three 291 explanations for birth order effect, namely more infectious exposures in later-born children, a 292 higher level of hormonal exposures in first pregnancies and a higher level of microchimerism in 293 the later-born individuals (VON BEHREN et al. 2011) . In this study, we find that birth order effect 294 only exists in maternal sibling pairs, giving us a clue that the differences of hormonal exposures 295 during pregnancies may contribute to the phenotypic diversity of VHL patients in different birth 296 order. However, we don't have enough data to confirm the hypothesis. The specific mechanisms 297 for birth order effect in VHL families need further exploration. 298
In conclusion, this study provides definitive evidence of intra-familiar phenotypic variety in 299 VHL families including genetic anticipation and birth order effect. Clinicians should take the 300 position in the family tree into consideration when they are making surveillance plan for VHL 301 patients. Although we confirm that telomere shortening plays a role in the molecular mechanism 302 of phenotypic heterogeneity within VHL families, the detailed effect of inactivated VHL protein 303 on genomic instability remains unclear, and the explanation for birth order effect needs further 304 exploration. 305 306 Acknowledgments 307
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Figure 2
Birth order effect between the first-born siblings and the others in the same generation. 392
The first-born siblings displayed lower age-related penetrance than the others for overall tumors 393 (A). Among siblings with an identical affected mother, the birth order effect became more evident 394 (B). When the mutated VHL allele was from fathers or the origin was not clear, the effect 395 disappeared (D). 396 
